Sunshine Biopharma
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $8,435 | $9,303 | $7,541 | $7,680 |
Gross Profit | 2,801 | 2,305 | 2,311 | 2,525 |
EBITDA | -917 | -786 | -1,169 | -1,144 |
EBIT | -982 | -837 | -1,212 | -1,187 |
Net Income | -1,197 | -494 | -1,283 | -1,250 |
Net Change In Cash | 8,435 | 9,303 | 7,541 | 7,680 |
Free Cash Flow | -1,877 | -5,150 | -3,884 | -2,993 |
Cash | 12,206 | 11,507 | 17,434 | 16,292 |
Basic Shares | 1,267 | 49 | 32 | 11 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $24,092 | $4,345 | $228 | $71 |
Gross Profit | 8,339 | 1,696 | 110 | 45 |
EBITDA | -3,824 | -26,446 | -12,094 | -2,601 |
EBIT | -3,973 | -26,471 | -12,107 | -2,615 |
Net Income | -4,506 | -26,744 | -12,765 | -897 |
Net Change In Cash | 24,092 | 4,345 | 228 | 71 |
Free Cash Flow | -9,563 | -5,553 | -1,829 | -658 |
Cash | 16,292 | 21,826 | 2,045 | 989 |
Basic Shares | 12 | 7 | 1 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.94 |
2024-06-30 | -$9.94 |
2024-03-31 | -$2 |
2023-12-31 | -$5 |
